MultiplexDX is an international corporation established in 2015 consisting of two units: MultiplexDX Inc. located in Maryland U.S.A. and MultiplexDX s.r.o. located in Slovakia. Our main goal is to eliminate cancer misdiagnosis by launching 98% accurate, quantitative and accessible diagnostic tests. We also operate a boutique oligohouse offering highly specialized custom oligonucleotides to the research community. The primary objectives of the company are: i) development of the technologies and the products for molecular diagnostic markets superior to currently available products; ii) core facility service using proprietary Multiplex TM technology iii) development of hi-tech 3D digital pathology services. Find out more about MultiplexDX on our official website and in social media: http://www.multiplexdx.com/ https://www.facebook.com/multiplexdx/ https://twitter.com/@multiplexdx http://bit.ly/MDXGooglePlus https://www.youtube.com/c/multiplexdx